The Comparison of Impact of Myo-inositol in combination with Metformin versus Metformin alone on Androgenic Features of PCOS patients
Journal of Rawalpindi Medical College · 31.03.2026 · 30 (1)
DOI: 10.37939/jrmc.v30i1.2948 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Rawalpindi Medical College, online erschienen am 31.03.2026. Verfasst von Hira Ehsan Khattak und 5 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Objective
To compare the effects of a combination of Myo-inositol and Metformin versus Metformin alone on hirsutism and acne in PCOS patients.
Methods
A total of 114 adult PCOS patients with hirsutism as well as acne underwent an 8-months randomization (September 2022 to May 2023) at Khyber Teaching hospital Peshawar outpatient department of gynecology and obstetrics, to one of the two treatments (double blinded study), where Group A included of 57 individuals taking combination of 500 mg of oral Metformin three times each day and Myo-inositol 4000 mg once daily; Group B included 57 individuals taking 500 mg of oral Metformin three times each day as single therapy. All hormonal, metabolic, and clinical indicators were assessed at the initial and eight-month points after the commencement of medication.
Results
A Significant difference was noted in terms of mean change in Farriman-Gallwey score in Group A (n=55), 3.59±0.81, versus Group B (n=54), 4.68±0.55 (p=0.00). Similarly, there was a notable improvement in mean change in Global acne score in Group A 1.51±0.50 when compared to Group B 2.38±0.67 (p =0.00), similarly there was significant differences between Group A 33.2±3.01 and Group B 41.5±32.99 in terms of mean serum Total testosterone levels p=0.00 and significant difference between Group A 95.56±5.71 and Group B 146.70±15.75 in terms of mean serum DHEA levels p=0.00.
Conclusion
By balancing hormones and improving metabolic profile, Myo-inositol and Metformin, when used in combination, are more successful in treating hirsutism and acne in adult PCOS patients as compared to metformin alone. Keywords: Polycystic ovarian syndrome, hirsutism, myo-inositol, metformin
Zitieren
APA
Khattak, H. E., Mahrukh, S. K., Ullah, A., Zahid, M., Gul, S., & Khan, A. (2026). The Comparison of Impact of Myo-inositol in combination with Metformin versus Metformin alone on Androgenic Features of PCOS patients. Journal of Rawalpindi Medical College, 30(1). https://doi.org/10.37939/jrmc.v30i1.2948
Vancouver
Khattak HE, Mahrukh SK, Ullah A, Zahid M, Gul S, Khan A. The Comparison of Impact of Myo-inositol in combination with Metformin versus Metformin alone on Androgenic Features of PCOS patients. Journal of Rawalpindi Medical College. 2026;30(1). doi:10.37939/jrmc.v30i1.2948
BibTeX
@article{Khattak2026,
author = {Khattak, Hira Ehsan and Mahrukh, Syeda Khadija and Ullah, Atif and Zahid, Muhammad and Gul, Sadia and Khan, Ayesha},
title = {The Comparison of Impact of Myo-inositol in combination with Metformin versus Metformin alone on Androgenic Features of PCOS patients},
journal = {Journal of Rawalpindi Medical College},
year = {2026},
volume = {30},
number = {1},
doi = {10.37939/jrmc.v30i1.2948}
}
EUVIMED